Strategic expansion Digitas Health has strong growth signals with a leadership expansion in 2026 and a notable Cannes Lions performance, indicating an opportunity to engage on high-level strategic, multi-market healthcare campaigns and integrated creative solutions.

Pharma focus Awards and work in pharma, including Pharma Grand Prix for Novartis and ongoing partnerships with AstraZeneca, suggest target opportunities in pharmaceutical brand communications, regulatory-compliant digital experiences, and patient-centric campaigns.

Publicis network leverage As part of Publicis Healthcare Communications Group, Digitas Health can be positioned to cross-sell within a large agency ecosystem, offering end-to-end health marketing solutions and leveraging shared data, tech, and media capabilities.

Senior leadership access Recent appointment of a chief executive-level project management and client operations leader signals potential for formalized program management, governance, and scalable operating models favorable to enterprise healthcare brands seeking complex, multi-channel execution.

Reciprocal partnerships Existing partnerships with Janssen/J&J, AstraZeneca, and GSK indicate continued demand for strategic creative and digital services; sales outreach can emphasize deep pharma collaboration, regulatory-compliant digital assets, and measurable ROI.